SUBSCRIBE
SUBSCRIBE

Synexa Life Sciences

Synexa Life Sciences is a biomarker and bioanalytical lab CRO, specialising in the development, validation and delivery of a wide range of complex and custom-designed assays.

With a team of over 200 staff across three global laboratory locations; Manchester, Turku (Finland) and Cape Town, we provide innovative solutions to support our customers to achieve their clinical milestones.

Our main areas of expertise include biomarker identification and development, large and small molecule clinical bioanalysis, (soluble) biomarker analysis (utilising MSD, LC-MS/MS, ELISA, RIA, fluorescence and luminescence-based technologies), cell biology (including flow cytometry, ELISpot and Fluorospot) and genomic services to support clinical trials and translational studies.

We pride ourselves on our deep scientific expertise and ability to tackle complex problems, translating them into robust and reliable assays to support clinical trial sample analysis.

NEWS
Employees Walking In And Out Of The Door, Some Were Leaving Their Job And Some Were Being Hired At The Same Time. Full Length, Isolated On Solid Color Background. Vector, Illustration, Flat Design, Character.
Layoffs
ImmunityBio to Lay Off 16, Will Likely Need Additional Capital
ImmunityBio will lay off 16 employees in California and said it expects to need more funding to commercialize Anktiva, approved in April for non-muscle invasive bladder cancer.
September 4, 2024
 · 
2 min read
 · 
Angela Gabriel
External view of Eli Lilly's world headquarters in Indianapolis
Deals
Lilly, Haya Ink Potential $1B Drug Discovery Deal to Target Obesity and Metabolic Conditions
Under a multi-year agreement announced Wednesday, Eli Lilly will leverage Haya Therapeutics’ proprietary RNA-guided genome platform to identify drug targets to address the chronic conditions.
September 4, 2024
 · 
2 min read
 · 
Kate Goodwin
Roche's signage at its office in France
Multiple sclerosis
Roche Touts Phase II MS Data on Heels of Sanofi’s Late-Stage Stumbles
Days after Sanofi reported back-to-back failures for its BTK inhibitor, Roche’s fenebrutinib on Wednesday scored a mid-stage win in relapsing multiple sclerosis, demonstrating near-total elimination of disease activity.
September 4, 2024
 · 
2 min read
 · 
Tristan Manalac
Pictured: Nasdaq headquarters in New York/iStock,
IPO
Lilly Partner BioAge Files for IPO to Advance Obesity Candidate
BioAge will use the proceeds from the initial public offering to move its oral apelin receptor agonist azelaprag past its Phase III STRIDES study and into a registrational Phase III trial.
September 4, 2024
 · 
2 min read
 · 
Tristan Manalac
3D illustration of neurons
Alzheimer’s disease
Athira’s Small Molecule Injection for Alzheimer’s Flops in Phase II/III Study
The investigational injection fosgonimeton appeared to have better efficacy in patients with more severe disease, according to post-hoc subgroup analyses, though none resulted in statistically significant effects.
September 4, 2024
 · 
2 min read
 · 
Tristan Manalac
MRI scans of a human brain
Neuroscience
Recursion Reports Thin Mid-Stage Efficacy Data for Rare Brain Disease Therapy
Recursion’s oral drug candidate for cerebral cavernous malformation showed no improvements in patient- or physician-reported outcomes at 12 months. The biotech will engage with the FDA to determine the need for an additional study.
September 4, 2024
 · 
2 min read
 · 
Tristan Manalac
Medical characters fighting the epidemic flat vector concept operation hand drawn illustration
Business
Lilly, Pfizer Take Meds Straight To Consumers in Renewed DTC Push
Big Pharma has finally gotten its arms around something advocates have wanted for a long time: direct-to-consumer sales. Eli Lilly and Pfizer are leading the way.
September 4, 2024
 · 
5 min read
 · 
Annalee Armstrong
Illustration of two people talking, trying to connect
Career Advice
Manager’s Toolbox: How to Have Difficult Conversations
Having difficult conversations with the right mindset can build trust and further develop your relationship with your team.
September 4, 2024
 · 
6 min read
 · 
Bruce Wu
Illustration of manager in tug of war
Management
Stuck in the Middle: How Millennial Managers Can Bridge Generational Gaps
Getting caught between younger team members and older bosses can be stressful for millennial managers. A leadership expert and millennial manager share tips for bridging the gap between these groups.
September 4, 2024
 · 
4 min read
 · 
Angela Gabriel
Load More
Visit website
Email Us
IN THE PRESS
Press Releases
Waters Sets a New Benchmark for Robustness and Sensitivity for High-Throughput Labs with the Xevo TQ Absolute XR Mass Spectrometer
June 2, 2025
 · 
4 min read
BioMidwest
Inotiv, Inc. Announces New Site Openings and Expansions Supporting Additional Capacity and Service Offerings
December 8, 2022
 · 
4 min read
Business
Parexel Announces Strategic Collaboration with Synexa Life Sciences and Drawbridge Health for COVID-19 Clinical Serology Testing Solution
November 2, 2020
 · 
4 min read
JOBS